Cargando…

Risk factors for immune-related adverse events: what have we learned and what lies ahead?

Immune checkpoint inhibitors (ICIs) have heralded the advent of a new era in oncology by holding the promise of prolonged survival in severe and otherwise treatment-refractory advanced cancers. However, the remarkable antitumor efficacy of these agents is overshadowed by their potential for inducing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaoyan, Shi, Yuequan, Zhang, Dongming, Zhou, Qing, Liu, Jia, Chen, Minjiang, Xu, Yan, Zhao, Jing, Zhong, Wei, Wang, Mengzhao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565046/ https://www.ncbi.nlm.nih.gov/pubmed/34732257 http://dx.doi.org/10.1186/s40364-021-00314-8

Ejemplares similares

Harness the synergy between targeted therapy and immunotherapy: what have we learned and where are we headed?
por: Liu, Xiaoyan, et al.
Publicado: (2017)

Paradigm Shifts in Cardiac Pacing: Where Have We Been and What Lies Ahead?
por: Ballantyne, Brennan A., et al.
Publicado: (2023)

Violence against children in the time of COVID-19: What we have learned, what remains unknown and the opportunities that lie ahead
por: Fore, Henrietta H.
Publicado: (2021)

Disease encumber-What lies ahead??
por: Damle, S. G.
Publicado: (2015)

Looking back and what lies ahead
por: Chang, David
Publicado: (2022)

Structural biology data archiving – where we are and what lies ahead
por: Kleywegt, Gerard J., et al.
Publicado: (2018)

The Search for Resistance to Cassava Mosaic Geminiviruses: How Much We Have Accomplished, and What Lies Ahead
por: Fondong, Vincent N.
Publicado: (2017)

A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead
por: Horgan, Claire, et al.
Publicado: (2023)

RESEARCH INITIATIVES: What Lies Ahead for Nanotechnology?
por: Stemp-Morlock, Graeme
Publicado: (2009)

Malaria Eliminating: What Lies Ahead of Iran?
por: Ebrahimzadeh-Leylabadlo, Hamed
Publicado: (2018)

Diabetes: What Challenges Lie Ahead for Vietnam?
por: Ngoc, Nguyen Bich, et al.
Publicado: (2020)

Parkinson’s disease therapy: what lies ahead?
por: Wolff, Andreas, et al.
Publicado: (2023)

Gene patents and personalized medicine - what lies ahead?
por: Chandrasekharan, Subhashini, et al.
Publicado: (2009)

What Lies Ahead?: Scientists Look into Their Crystal Balls
Publicado: (2016)

COVID-19 Pandemic in India: What Lies Ahead
por: Mitra, Prasenjit, et al.
Publicado: (2020)

Healthcare and medical education reforms in India: What lies ahead?
por: Kumar, Raman
Publicado: (2013)

Driving Chromatin Organisation through N6-methyladenosine Modification of RNA: What Do We Know and What Lies Ahead?
por: Selmi, Tommaso, et al.
Publicado: (2022)

A Summary of 2018 and What Lies Ahead for Diabetes Therapy in 2019
por: Evans, Marc, et al.
Publicado: (2019)

A Summary of 2018 and What Lies Ahead for Rheumatology and Therapy in 2019
por: Fleischmann, Roy
Publicado: (2019)

A Summary of 2018 and What Lies Ahead for Dermatology and Therapy in 2019
por: Menter, Alan, et al.
Publicado: (2019)

South African Journal of Sports Medicine: 2020 what lies ahead?
por: Lambert, Mike
Publicado: (2020)

Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
por: Xu, Yan, et al.
Publicado: (2022)

Circulating cytokines associated with clinical outcomes in advanced non‐small cell lung cancer patients who received chemoimmunotherapy
por: Shi, Yuequan, et al.
Publicado: (2021)

Clinical characteristics and outcomes of immune checkpoint inhibitor-induced diabetes mellitus
por: Liu, Jia, et al.
Publicado: (2022)

Clinical significance of DNA damage response mutations in stage I and stage IIIa NSCLC
por: Zhang, Haoran, et al.
Publicado: (2023)

Clinicopathological characteristics of lung cancer in patients with systemic sclerosis
por: Chen, Minjiang, et al.
Publicado: (2020)

Drugs in Context Editorial: Review of 2020 and what lies ahead in therapeutic interventions
por: Anderson, Sarah L, et al.
Publicado: (2021)

Southeast Asia after a year: what lies ahead for the health of the region?
por: The Lancet Regional Health – Southeast Asia
Publicado: (2023)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

What lies ahead of us? Collective future thinking in Turkish, Chinese, and American adults
por: Mert, Nazike, et al.
Publicado: (2022)

Functional characterization of prokaryotic dark matter: the road so far and what lies ahead
por: Escudeiro, Pedro, et al.
Publicado: (2022)

Psychological Interventions for Dementia Caregivers: What We Have Achieved, What We Have Learned
por: Cheng, Sheung-Tak, et al.
Publicado: (2019)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

SARS: What have we learned?
Publicado: (2003)

Drawing what lies ahead: False intentions are more abstractly depicted than true intentions
por: Calderon, Sofia, et al.
Publicado: (2018)

The COVID-19 Pandemic and Post-Infection Irritable Bowel Syndrome: What Lies Ahead for Gastroenterologists
por: Chan, Walter W., et al.
Publicado: (2022)

Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge
por: Laatikainen, O., et al.
Publicado: (2021)

Lymphopenia in Esophageal Cancer: What Have We Learned?
por: Wang, Jia-Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2urspd8jgr6onu1naf7pv4nbtl